- Janine Schuurman to compose agenda for the conference’s special 5th anniversary edition
- On-demand lectures now available from 2024’s edition
Porto, Portugal – 9th January 2025: The Antibody Series (TAS), a leading international conference focused on innovation and advancing the field of antibody discovery and development, is pleased to announce Dr. Janine Schuurman as Chair of the highly anticipated 5th edition. The conference will take place from September 9-12, 2025, in Porto, Portugal.
Dr. Schuurman, an esteemed expert in the antibody field, brings a wealth of experience to the role. She holds a PhD from the University of Amsterdam, joining Genmab in 2000 as one of the first scientists, with her most recent position being Senior Vice President, Head Antibody Research & Technology. She joined The Antibody Society’s Board of Directors in 2020 and currently serves as President. She is a co-inventor of many therapeutic antibodies including FDA-approved therapeutics RYBREVANT® (amivantamab) and (T)EPKINLY® (epcoritamab), and of the DuoBody®, HexaBody® and HexElect® technologies.
As TAS Chair, Dr. Schuurman will set the stage with a forward-thinking scientific agenda, bringing together leading experts from academia, biotech, and pharma to discuss the future of antibody therapeutics.
Dr. Schuurman commented: “I’m honoured to chair this important and special milestone event in September. The antibody field continues to evolve at a rapid pace, and I look forward to curating a scientific program that highlights current and future antibody innovations on the horizon.”
The Antibody Series conference is hosted by FairJourney Biologics. The annual event attracts more than 200 invited global leaders across biotech, pharmaceutical, venture capital, and academic sectors and is co-joined by over 4,000 registered participants from the scientific community online.
Dr. Janine Schuurman Appointed Chairwoman of The Antibody Series 2025
Janine Schuurman to compose agenda for the conference’s special 5th anniversary edition On-demand lectures now available from 2024’s edition Porto, Portugal – 9th January 2025: The Antibody Series (TAS), a leading international conference focused on innovation and advancing the field of antibody discovery and development, is pleased to announce Dr. Janine Schuurman as Chair of the highly anticipated 5th edition. The conference will take place from September 9-12, 2025, in Porto, Portugal. Dr. Schuurman, an esteemed expert in the antibody field,
Save the Date for TAS 2025
FairJourney Biologics Announces Special 5th Anniversary Edition of The Antibody Series in Porto, Portugal - Official dates released 9 – 12 September 2025 - On-demand now available from 2024’s Edition Porto, Portugal – FairJourney Biologics is excited to announce official dates for the highly anticipated return of The Antibody Series conference next year, confirmed for September 9-12, 2025 and returning to Porto, Portugal. The 5th anniversary edition promises to be a very special milestone event in continuing to bring together leading experts in
Your Guide to Joining TAS 2024
Everything you need to know about the 4th edition of The Antibody Series Overview Details In-person: 4 – 6 September, 2024 Location: Madeira Island, Portugal Free on-demand: Register here Chairman: Dr. Paul Parren, CSO at Gye About The Antibody Series is the fastest growing antibody conference of its kind. Started in 2021, in Porto, Portugal, the premier annual conference brings together international experts in the field of antibody discovery and development to discuss innovative topics and trends in the industry. Attendees benefit from
Dr Paul Parren announced as Chairman of TAS 2024
Dr Paul Parren is dedicated to translating antibody knowledge into innovative therapeutics and technologies. Holding a PhD in molecular immunology from the University of Amsterdam (1992), Prof. Paul Parren is the founder and CSO at Gyes BV, a start-up company pioneering multispecific antibodies.